Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have come a long way over the past few decades focusing on managing symptoms and ...

Previous applications of TUS were limited, as they were imprecise and too weak to target areas deeper in the brain. Parkinson ...

The common myths about Parkinson’s disease and treatments - People have lots of misconceptions about Parkinson’s disease and how it develops, here are the ...

The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, ...

With U.S. diagnoses of Parkinson's expected to reach 1.2 million by 2030, research is in full swing, and treatments ...

Weekly intramuscular injections of rotigotine extended-release microspheres are linked to significant symptom improvement in ...

Researchers led by a team from the University of Bath in the UK have achieved just that in a basic worm model of Parkinson's.

"Furthermore, patients with RLS who were not treated with dopamine agonists tended to be at increased risk of developing ...

Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson's disease spectrum Positive results across all three Phase 3 TEMPO trials ...

Researchers in the UK have started recruiting patients for a large-scale trial that will test a battery of Parkinson's ...

Parkinson’s breakthrough could unlock treatments for devastating disease - Scientists have developed a groundbreaking new ...